Home J&J leukemia drug cuts death risk vs. chemo in new patients: study
 

Keywords :   


J&J leukemia drug cuts death risk vs. chemo in new patients: study

2015-12-07 03:47:40| Food - Topix.net

Johnson & Johnson's and AbbVie's cancer drug Imbruvica significantly reduced the risk of death and disease progression compared with chemotherapy in previously untreated patients with a type of leukemia in a late stage study, paving the way for an expanded approval of the medicine. In the trial of 269 patients aged 65 and older with chronic lymphocytic leukemia , Imbruvica decreased risk of death by a statistically significant 85 percent compared with the chemotherapy chlorambucil, researchers reported on Sunday.

Tags: study death risk drug

Category:Food and Related Products

Latest from this category

All news

»
04.11Paper Excellence Group Rebrands as Domtar
04.11Registration Open for 2025 Waterborne Symposium
04.11ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending
04.11Natracare Launches E-Commerce Site
04.11Tropical Depression Eighteen Graphics
04.11The Honey Pot Launches Witch Hazel Intimate Wash & Wipes
04.11Remnants of Patty Graphics
04.11Tropical Depression Eighteen Forecast Discussion Number 4
More »